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S u m m a r y  
 
A key element in the life of cells in culture is the number 
of cell divisions, not their life time in culture. Serially in vivo 
transplanted cells also exhibit a finite lifetime, which means 
that the cell aging is not unique only to a cell culture. There 
are theories  suggesting that the aging of cells in culture may 
be associated with the aging of the organism from which they 
were obtained. Cells may stop dividing because of replicative 
aging, which is the result of telomere shortening. The aging 
process in cells may be induced by an intracellular process 
associated with shortening and uncapping of telomeres and 
environmental factors of a stochastic nature, among the most 
important of which is oxidative stress. The loss of telomeres 
beyond a critical value eventually induces antiproliferative 
signals that result in an aging. Telomeres give information 
about the end of replication; their function can be however 
recreated. Insertion of protein genes, comprised in 
telomerase, to aging human cells increases the length of their 
telomeres to lengths typical of young cells. The cells then 
exhibit all the characteristics of young nucleated cells. 
Telomerase is not only the central mechanism for regulating 
cells life, but it is also a mechanism that can be  resumed, 
extending the replicative period of cells , comprising markers 
of gene expression characteristic of young cells, life. It is not 
known in what way replicative aging of cells is played by 
oxidative DNA damage, exposure to UV, oncogenes, which 
are independent of telomere shortening. 
 
 
S t r e s z c z e n i e  
 
Kluczowym elementem w długości życia komórek w 
hodowli jest liczba podziałów komórkowych, a nie czas 
życia w kulturze.  Komórki przeszczepiane seryjnie in vivo 
wykazują także skończoną żywotność, co oznacza, że 
starzenie komórek nie jest charakterystyczne tylko dla 
hodowli komórkowych.  Istnieją teorie, które sugerują, że 
starzenie się komórek w hodowli może być związane ze 
starzeniem się organizmu, z którego zostały one otrzymane. 
Komórki mogą przestać się dzielić z powodu starzenia 
replikacyjnego, które jest wynikiem skracania telomerów. 
Starzenie się w tym procesie komórek może być indukowane 
przez wewnątrzkomórkowy program związany ze 
skracaniem się i zmianami budowy telomerów (tzw. 
uncapping) oraz czynniki środowiskowe o charakterze 
stochastycznym, spośród których najważniejszym jest stres 
oksydacyjny. Utrata telomerów, po przekroczeniu wartości 
krytycznej, indukuje ostatecznie sygnały antyproliferacyjne, 
których skutkiem jest starzenie się. Telomery są więc 
zegarem replikacyjnego wyczerpania się, ich funkcja może 
być jednak odtwarzana. Wstawienie genów białek 
wchodzących w skład telomerazy do starzejących się 
komórek ludzkich powoduje wydłużenie ich telomerów do 
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długości typowej dla młodych komórek. Komórki wykazują 
wtedy wszystkie cechy charakterystyczne dla młodych 
komórek jądrzastych. Telomeraza jest nie tylko centralnym 
mechanizmem regulującym czas życia komórek, ale także 
mechanizmem, który może być ponownie włączony, 
przedłużając replikacyjny okres życia komórek, 
posiadających markery ekspresji genów charakterystycznych 
dla młodej komórki. Nie wiadomo, jaki wpływ na 
replikacyjne starzenie się komórek ma oksydatywne 
uszkodzenie DNA, ekspozycja na UV, onkogeny ras, które są 
niezależne od skracania się telomerów. 
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A cell culture is characterized by a limited number 
of cell divisions. In the process of cells aging changes 
in cell morphology and inhibition of proliferation take 
place [1]. One of the most important issues in the 
research on aging is whether the changes observed in 
replicative aging can be correlated with the pathways 
and mechanisms of cell aging in situ. Another 
important and controversial aspect of replicative aging  
in cell culture is the process leading to the aging of 
phenotype achieved independently of proliferation [2]. 
It is suggested that phenotype aging is the final 
common pathway for actively dividing cells, in which 
signaling and/or metabolic imbalances may occur. It 
can be deducted that the cells may not be able to 
differentiate in vivo in a culture due to inadequate 
culture environment [2]. However, establishing a 
relationship is not required to use cell culture as a tool 
to carry out a research on aging mechanisms. There is 
evidence of the correlation of the aging cells in a 
culture with the aging cells in vivo, particularly in the 
processes present in both. To identify of cellular 
senescence in cell culture the authors used e.g. 
methods: telomeric repeat amplification protocol, 
senescence-associated β-galactosidase activity, 




There are two main theories of cellular aging. One 
of them is defined as a damage model. It is 
characterized by impaired ability to repair 
deoxyribonucleic acid (DNA), causing randomly 
accumulated damages or mutations in DNA, 
ribonucleic acid (RNA) and the accumulation of 
altered proteins leading to the loss of proliferative 
capacity [3, 4] .  
The second hypothesis assumes that aging is a 
genetically programmed process. Experimental 
evidence supporting theories of genetically 
programmed cell aging were provided in the researches 
of Pereira-Smith and Smith, and Sugawara et al [5, 6]. 
By fusing different immortal human cell lines Pereira-
Smith and Smith suggest that the loss or inactivation of 
one of the many genes allows cells to avoid aging 
process [5]. If this hypothesis is confirmed it would 
allow the mapping of genes involved in cell aging [6, 
7]. Preliminary mapping by Sugawara et al. of the gene 
of aging on the chromosome 1. was presented with the 
use of three independent experimental methods using 
human cells, among others, and immortal hamster cells 
[6]. Chromosome transfer experiments have shown that 
the introduction of a single copy of human 
chromosome 1, has renewed the program of aging in 
some immortal cell lines. The use of the technology of 
chromosome transfer has enabled  mapping of the gene 
of aging  on more than ten human chromosomes [7]. 
This method demonstrates that cell aging is controlled 
by genes that are activated, or whose functions are 
revealed at the end of the cell life. Faults in these genes 
allow the cells to avoid programmed process of aging 
and they become immortal. Perpetuation leads to 
progression of tumor cells. According to this 
hypothesis, aging is an active process controlled by 
definable genes; immortality is caused by damage or 
defects in these genes. This theory is based on the 
research conducted by Pereira-Smith and Smith, which 
showed that various immortal cell lines can 
complement each other when combined. This theory 
states that the introduction of a given human 
chromosome causes aging in some cell lines [5]. 
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MECHANISMS AND MOLECULAR BASIS  
OF CELLULAR AGING 
 
In vitro aging process is accompanied by loss of 
proliferative capacity, which results in a decrease in 
replication. It is necessary to identify biological 
markers of the aging process, which facilitate the 
identification of senescent cells in culture and in vivo. 
Some of these indicators are presented in Tab. 1. and 
include the insulin-like growth factor 1 (IGF-1), 
epidermal growth factor (EGF), c-fos, beta-
galactosidase. IGF-1 is produced by many cell types 
and plays an important role in the regulation of cell 
proliferation. Ferber and colleagues studied the 
production of IGF-1 which made it possible to detect 
the location of the IGF-1 receptor, which was explored 
in normal diploid fibroblasts [8]. The observations 
showed that the production of IGF-1 in messenger 
RNA (mRNA) decreased to undetectable level in the 
aging cells. Another biological marker, which is 
variously placed in aging cells,  is the EGF. EGF 
signaling indicates the existence of disorders in non-
proliferating aging human diploid fibroblasts below 
receptor binding. The lysates of young and aging WI-
38 cells of the proteolytic activity targeted  to the EGF 
receptor were compared [9]. The results of the 
experiments indicate that proteases cleave the EGF 
receptor, and the product is present only in aging 
fibroblasts. The production of proto-oncogene c-fos is 
important in the regulation of growth because it is a 
part of the transcriptional activator AP-1. In 1990, 
Seshadri and Campisi showed the loss of c-fos in aging 
WI-38 cells, which suggests that selective repression of 
c-fos led to the lack of proliferation [10, 11]. 
 
Table. I. Markers of aging in cell lines [10, 11] 
Tabela. I. Markery starzenia się w liniach komórkowych.  
               [10, 11] 
 
 Cell line  bio-
markers 
Description 
 WI-38, HS74, 
IMR-90  
 IGF-1  Senescent cells do not produce mRNA 
for IGF-1 
 WI-38   EFG  Altered form of EGF produced in 
senescent cells 
 WI-38   c-fos  Repressed in late passage cells 
 WI-38, IDH4, 
NHEK, CMV-
MJ, HCA2  
 SA-β-Gal  Expressed in senescent cells but not in 
quiescent or terminally differentiated 
cells 
It has been observed that the placement of different 
chromosomes can independently induce aging in the 
same line of immortal cells using the immortal lines 
derived from cancer cells mapping of senescence genes 
on chromosome 18 is enabled [12]. This finding 
suggests that there are many aging pathways and that 
immortal cells arise due to defects present in each of 
these pathways. The aging process can be activated by 
a single pathway, and the perpetuation of cells  can be 
triggered by mutations within one of genes encoding 
proteins that are involved in this pathway. An 
alternative hypothesis is that the aging program is 
activated by several independent pathways. Immortal 
cells require at least one mutation in each pathway. 
Mutations that affect only one pathway do not 
immortalized cells but extend their lifetime. For 
example, infection with simian virus 40 (SV40) (which 
deactivates RB and p53 proteins) extends the life of 
cells but does not lead to the immortality of the 
infected cells [13]. Essential factors that lead to 
immortality of SV40-infected human cells are an 
additional genetic change or the loss of a chromosome 
6 [14]. Antisense regulation of RB and p53 mRNA 
also results in longer cells life without immortalization 
[15]. Numerous hypotheses of aging are consistent 
with  multistage immortalization observed in 
chemically induced pathway [16]. Furthermore, the 
inability to assign immortal cells to the same group 
confirms this hypothesis [17]. 
 
MARKERS AND SENESCENCE GENE  
 
Using the technique of chromosome transfer 
suggested by Sugawara et al human genes of aging 
were mapped. Chromosome 9p21 which belongs to the 
region where p16 gene of aging, which relates to this 
region, was mapped enabling the activation of the 
aging process in the region of chromosome [18]. The 
protein p16 is an inhibitor of cyclin-dependent kinases 
CDK4 and CDK6; it is a major regulator of the G1 
phase cell cycle. In addition, p16 is mutated in many 
immortal cancer cells. It has been shown that p16 is 
modulated during cellular aging and its activity is 
enhanced in aging human cells. It acts as the main 
inhibitor of cyclin-dependent kinases in aging cells 
[19]. As p16 is mutated in many cell lines, and 
reintroduced to immortal cell lines pl6 causes induction 
of  the cellular aging process, it can be concluded that 
pl6 is the gene of aging mapped to 9p21 [20].  
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Two other genes of the control of cell cycles p53 
and Rb also demonstrate properties related to aging 
[14]. The p53 protein is an important factor regulating 
the passage of the cell through G1 phase. In response 
to DNA damage accumulation of normal (wild) p53 
protein takes place, resulting among other things in, 
transcriptional induction of p21 protein, which is an 
inhibitor of cyclin kinases [21]. Accumulation of p53 
protein is not due to de novo gene transcription. In 
response to DNA damage the activation of a cascade of 
kinases and other proteins, including ATM, ATR, 
Chk1, Chk2, CDC25C, and the interaction of p53 with 
mouse double minute 2 homolog (MDM2) occur [22, 
23]. The result of this is the reduction of the 
degradation of p53 protein and thereby the increase in 
the level of this protein in the cell. Inhibition of G1 
phase kinases activity results in the accumulation of 
unphosphorylated Rb protein, which in turn causes the 
blockage of the cell cycle. Reintroduction of genes into 
some immortal cells inhibits the growth of them and 
leads to morphological changes characteristic of aging 
cells [24, 25]. In normal cells p53 and Rb proteins 
perform a negative role of regulators in the cell cycle, 
and that is why these proteins are controlled by other 
proteins, which enables the proper continuation of the 
cell cycle. In the aging cells the program is activated 
upon inhibition of DNA synthesis in the cell cycle, the 
consequence of which is the growth arrest in G1 phase. 
Rb and p53 are involved in one or several pathways 
that activate or influence the aging process. Deletions 
or mutations occurring in p53 and Rb genes may cause 
inability to activate the process of aging. p53 and Rb in 
the proper form is present in some immortal cells, and 
the genes that control their phosphorylation or other 
posttranslational modifications may be defective [24].  
 
REPRESSION OF THE ENZYME TELOMERASE 
 
Not only cell cycle regulation is associated with 
aging process. Different functions of the aging gene 
that are linked with repression of the enzyme 
telomerase, which is responsible for the maintenance 
of telomeres in most immortal cell lines, is also 
involved. Telomeres are specialized structures at the 
ends of chromosomes, which consist of tandem 
repeated DNA sequences - (TTAGGG) and proteins 
associated with them such as telomeric repeat binding 
factor (TRF1) and TRF2 [26]. Telomeres function as a 
mitotic clock by setting the cell life [27]. In normal 
human somatic cells, which do not show telomerase 
activity, the telomeric DNA progressively stops 
shortening in the process of cell division. This results 
from the inability of DNA polymerases to replicate the 
linear ends of DNA molecules, or  it  dependents on 
some other mechanism of the final DNA degradation 
[27]. It is assumed that the cellular aging process 
begins when the telomeres reach a critically short 
length [27]. Immortal cancer cells have mechanisms 
that compensate for telomere shortening, usually by 
activating of telomerase, allowing them to stably 
maintain their telomeres and grow indefinitely [28]. 
Three components of the human enzymes of 
telomerase were identified: human telomerase RNA 
the component of human telomerase RNA component 
(hTERC), also known as hTR, which acts as a template 
for telomere repeat synthesis,  telomerase 
boundprotein-l/telomerase protein component 1 
(TP1/TLPI), which is similar to the Tetrahymena 
telomerase protein p80. and the catalytic subunit of 
telomerase reverse transcriptase and containing human 
telomerase reverse transcriptase (hTERT), also known 
as hEST2/hTRT, which were isolated on the basis of 
their similarity counterparts in yeast and Euplotes 
aediculatus [29].   
 
Fig. 1. Transcriptional repression of hTERT gene by a 
telomerase repressor gene on chromosome 3 [29] 
Ryc. 1. Represja transkrypcji genu telomerazy hTERT przez 
genu represorowego na chromosomie 3 [29] 
 
Of interest is the way in which components activate 
and regulate the human telomerase and how they are 
regulated by factors that may play a role in aging and 
cellular immortality and carcinogenesis. hTERC and 
hTEPI are present in normal cells: mortal and 
immortal. hTERT expression is detected in telomerase 
positive cells but not detected in telomerase negative 
cells. Furthermore, the introduction of the hTERT gene 
promoter constructively deprive them of telomerase 
activity thus is the catalytic subunit of telomerase. 
hTERT expression and repression leads to wrong 
regulation of telomerase, and thereby adversely affect 
the viability of normal cells  [30].   






Nowadays it is known that the cells cease to divide 
due to old age or due to terminal differentiation (e.g. 
nerve cells). It is assumed that the aging of cells also 
occurs in vivo and that the life expectancy and 
replicative lifetime of cells are under common genetic 
control. There are suggestions that the aging of cells 
prevents the formation of tumors in them. On the other 
hand, the old human fibroblasts stimulate the growth of 
epithelial tumor cells, but have no effect on normal 
cells. This effect may be caused either by a direct 
contact of old fibroblasts and tumor cells as well as by 
soluble factors produced by old fibroblasts. This 
phenomenon is referred to as senescence-associated 
secretory phenotype (SASP). The main hypothesis of 
cellular aging is the shortening of telomeres [27]. This 
theory constitutes  the explanation of the mitotic clock 
in the replication process of cellular aging. But there is 
also evidence to suggest that signals other than 
telomere shortening may be the cause of cell aging. 
Cellular aging is included by oxidative stress, and 
terminal differentiation as well as changes in DNA 
methylation. It is possible that oxidative stress causes 
aging of cells by affecting the rate of telomere 
shortening. Further studies will help to determine 
whether telomere shortening is the main mechanism of 
induction of cellular aging, or if there are other 
telomere-independent inducers also involved in this 
process. The cellular process of  aging is controlled by 
many genes. Important in the regulation of genes in 
this process are mutated and deactivation immortal 
cancer cells that have avoided aging. This process can 
be restored in these cells by the introduction of normal 
chromosomes, enabling the mapping and cloning of 
genes. The basic functions of these genes are helpful in 
explaining of regulation, cell cycle control and 
regulation of telomerase. All these factors are 
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